Have your own idea? Try our Stock Screener
Finnish (OMX) Pharma Industry Analysis
UpdatedJan 19, 2025
DataAggregated Company Financials
Companies2
- 7D9.4%
- 3M3.7%
- 1Y14.5%
- YTD13.1%
All of the companies in the Pharma industry have been up over the last week, with the industry up 3.8%. Overall in the last year, the industry is flat. Earnings are forecast to grow by 9.3% annually.
Industry Valuation and Performance
Has the Finnish Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 19 Jan 2025 | €7.0b | €1.4b | €331.1m | 20.9x | 21x | 4.9x |
| Tue, 17 Dec 2024 | €5.9b | €1.4b | €331.1m | 17.8x | 17.9x | 4.1x |
| Thu, 14 Nov 2024 | €6.3b | €1.4b | €331.1m | 18.9x | 19x | 4.4x |
| Sat, 12 Oct 2024 | €6.8b | €1.3b | €231.7m | 29.1x | 29.3x | 5.4x |
| Mon, 09 Sep 2024 | €6.8b | €1.3b | €231.7m | 29.2x | 29.3x | 5.4x |
| Wed, 07 Aug 2024 | €6.0b | €1.2b | €217.1m | 67.5x | 27.7x | 4.9x |
| Fri, 05 Jul 2024 | €5.8b | €1.2b | €217.1m | 70x | 26.9x | 4.8x |
| Sun, 02 Jun 2024 | €5.3b | €1.2b | €217.1m | 79x | 24.5x | 4.4x |
| Tue, 30 Apr 2024 | €5.1b | €1.2b | €217.1m | 62.9x | 23.7x | 4.2x |
| Thu, 28 Mar 2024 | €4.9b | €1.2b | €217.1m | 62.1x | 22.5x | 4.1x |
| Sat, 24 Feb 2024 | €5.4b | €1.2b | €216.8m | 24.9x | 24.9x | 4.5x |
| Mon, 22 Jan 2024 | €6.0b | €1.2b | €173.2m | 34.9x | 34.9x | 5.2x |
| Wed, 20 Dec 2023 | €5.3b | €1.2b | €173.2m | 30.8x | 30.7x | 4.6x |
| Fri, 17 Nov 2023 | €5.2b | €1.2b | €173.2m | 30x | 30.2x | 4.5x |
| Sun, 15 Oct 2023 | €5.5b | €1.4b | €306.3m | 18.1x | 18.1x | 4.1x |
| Tue, 12 Sep 2023 | €5.3b | €1.4b | €306.3m | 17.4x | 17.4x | 3.9x |
| Thu, 10 Aug 2023 | €4.9b | €1.4b | €306.3m | 16x | 16.1x | 3.6x |
| Sat, 08 Jul 2023 | €5.1b | €1.3b | €336.0m | 15.1x | 15.2x | 3.8x |
| Mon, 05 Jun 2023 | €5.7b | €1.3b | €336.0m | 16.8x | 16.9x | 4.2x |
| Wed, 03 May 2023 | €6.0b | €1.3b | €336.0m | 17.8x | 17.8x | 4.4x |
| Fri, 31 Mar 2023 | €5.8b | €1.3b | €349.5m | 16.4x | 16.5x | 4.3x |
| Sun, 26 Feb 2023 | €6.5b | €1.3b | €339.0m | 18.5x | 19.2x | 4.9x |
| Tue, 24 Jan 2023 | €7.1b | €1.3b | €340.2m | 20.1x | 20.8x | 5.3x |
| Thu, 22 Dec 2022 | €7.5b | €1.3b | €340.2m | 21.4x | 22.1x | 5.7x |
| Sat, 19 Nov 2022 | €6.6b | €1.3b | €350.7m | 18.9x | 18.9x | 5x |
| Mon, 17 Oct 2022 | €6.1b | €1.1b | €201.7m | 30.3x | 30.3x | 5.7x |
| Wed, 14 Sep 2022 | €6.4b | €1.1b | €201.7m | 31.5x | 31.5x | 5.9x |
| Fri, 12 Aug 2022 | €6.6b | €1.1b | €201.7m | 32.6x | 32.6x | 6.1x |
| Sun, 10 Jul 2022 | €6.2b | €1.0b | €191.5m | 32.3x | 32.3x | 5.9x |
| Tue, 07 Jun 2022 | €5.3b | €1.0b | €191.5m | 27.8x | 27.7x | 5.1x |
| Thu, 05 May 2022 | €5.1b | €1.0b | €191.5m | 26.7x | 26.7x | 4.9x |
| Sat, 02 Apr 2022 | €5.9b | €1.0b | €193.8m | 30.3x | 30.2x | 5.6x |
| Mon, 28 Feb 2022 | €6.0b | €1.0b | €193.8m | 30.9x | 30.8x | 5.7x |
| Wed, 26 Jan 2022 | €4.9b | €1.0b | €186.5m | 26.3x | 26.3x | 4.8x |
Price to Earnings Ratio
26.3x
Current Industry PE
- There are only 2 companies in the Finnish Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 21% per year over the last three years.
- Revenues for these companies have grown 12% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Finnish Healthcare industry?
| FI Market | 2.20% | |
| Healthcare | 6.84% | |
| Pharma | 9.35% | |
| Pharma | 9.35% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ORNBV Orion Oyj | €49.37 | 9.4% +€595.7m | 14.5% | PE20.9x | |
| HRTIS Herantis Pharma Oyj | €1.63 | 0.6% +€201.6k | 7.2% | PB16.1x |